Abstract:The unique merits of aptamers, including specificity, high binding affinity, easy cell internalization, and rapid tissue accumulation abilities, have led aptamer–drug conjugates to evolve into one of the most attractive strategies for targeted drug delivery purposes. Nevertheless, the critical role of linkers in regulating anticancer efficacy of these conjugates, especially those engineered by automated modular synthesis techniques, has been rarely explored. In this work, we utilized Sgc8c aptamer and combretastatin A4 to develop three conjugates with either a phosphodiester bond linker, a disulfide bond linker, or a carbamate linker to study their payload release mechanisms and the influence on anticancer efficacy. These investigations allowed us to identify the unique activation pathway of the phosphodiester bond linker that is activated by both nucleophilic attack of glutathione and degradation caused by phosphodiesterase, which is highly associated with the higher cytotoxicity of the conjugate. Importantly, the understanding of the chemistry of phosphodiester bond linker activation allowed us to further design another XQ-2d-CA4 conjugate that can induce pancreatic cancer cells apoptosis in a more efficient manner.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.1c03013?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.1c03013</a>.DNA sequences, characterization, and identification of aptamer-CA4 conjugates, cell uptake efficiency of the conjugates, drug releasing mechanism investigations, and cell viability assays (<a class="ext-link" href="/doi/suppl/10.1021/jacs.1c03013/suppl_file/ja1c03013_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides

Design, synthesis, and biological evaluation of stapled ascaphin-8 peptides

Structure-Based Design Of Tripeptide Derivatives Of α-Aminoalkylphosphonate Esters For Prostate-Specific Antigen Inhibition

Design, Synthesis, and Antitumor Activity Study of All-Hydrocarbon-Stapled B1-Leu Peptides

Rational design of a new short anticancer peptide with good potential for cancer treatment

Optimization of Beclin 1-Targeting Stapled Peptides by Staple Scanning Leads to Enhanced Antiproliferative Potency in Cancer Cells

Design, Synthesis, Biological Evaluation and Cocrystal Structures with Tubulin of Chiral Β-Lactam Bridged Combretastatin A-4 Analogues As Potent Antitumor Agents.

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

An Effective Modification Strategy to Build Multifunctional Peptides Based on a Trypsin Inhibitory Peptide of the Kunitz Family

Unleashing the potential of natural biological peptide Macropin: Hydrocarbon stapling for effective breast cancer treatment

Design, Synthesis, And Biological Evaluation Of Hydantoin Bridged Analogues Of Combretastatin A-4 As Potential Anticancer Agents

Design, synthesis of combretastatin A-4 piperazine derivatives as potential antitumor agents by inhibiting tubulin polymerization and inducing autophagy in HCT116 cells

Therapeutic stapled peptides: Efficacy and molecular targets

Development of Combretastatin A-4 Analogues as Potential Anticancer Agents with Improved Aqueous Solubility

Fine Tuning the Properties of Stapled Peptides by Stereogenic Α-Amino Acid Bridges.

Synthesis and structural optimization of oncolytic peptide LTX-315

Regulating the Anticancer Efficacy of Sgc8–Combretastatin A4 Conjugates: A Case of Recognizing the Significance of Linker Chemistry for the Design of Aptamer-Based Targeted Drug Delivery Strategies

Dithiocarbamate-inspired Side Chain Stapling Chemistry for Peptide Drug Design

Branched -helical peptides enhanced antitumor efficacy and selectivity

A novel peptide stapling strategy enables the retention of ring-closing amino acid side chains for the Wnt/β-catenin signalling pathway

Further structural optimization and SAR study of sungsanpin derivatives as cell-invasion inhibitors